In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bionx Implants Inc.

Division of ConMed Corp.

Latest From Bionx Implants Inc.

Oakes, Lyman: Is This the Model for Building European Device Companies?

Despite outstanding clinical science, Europe has historically lagged behind the US, if not in medical device innovation, at least in device company creation. A vicious cycle of few start-ups, reluctant VCs, and a poor pool of experienced managers has kept company creation from exploding. But now former merchant bankers turned serial entrepreneurs, Herb Oakes and Dick Lyman, believe they have a better formula for starting device companies in Europe.

Medical Device Europe

Inion: Making Orthopedic Implants Fade Away

This Finnish company recently went public with a strategy built on bioabsorbable orthopedic devices with the goal of eventually making them bioactive as well.

Medical Device Strategy

Integra's Incremental Profitability Strategy

As a small company selling into the fragmented wound care markets, Integra was spending as much as it was making. As a platform biomaterials company, Integra faced partnership risk and stood to only get a cut of end-user revenues. It needed a source of direct revenues. A year ago, the company's new CEO began building a neurosurgery business through acquisitions, initially based on mature, revenue-producing products. The strategy seems to be working; the company reached profitability in the last quarter and now holds the third position in a fragmented neurosurgery market. But the incremental strategy that has brought Integra to profitability inherently has its limitations. Now that it has created a growth expectation, it needs to achieve critical mass, through increasingly larger acquisitions or home-run products.

Medical Device Strategy

The Softer Side of Sports Medicine

Resorbable biomaterials and improved arthroscopic tools form the backbone of innovation in sports medicine, and should, along with the aging baby-boomer population, spur growth in the field

Medical Device Strategy
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Gynecological, Urological
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ConMed Corp.
  • Conmed Corp.
  • Senior Management
  • Gerald Carlozzi, Pres. & COO
    Pertti Viitanen, Managing Dir., Finnish Operations
    Pertti Tormala, EVP, R&D
  • Contact Info
  • Bionx Implants Inc.
    Phone: (215) 643-5000
    1777 Sentry Pkwy. West
    Gwynedd Hall
    Blue Bell, PA 19422